Category: biologics
-
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
•
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Breadcrumb Trail Links GlobeNewswire Author of the article: Published Jan 13, 2025 • 16 minute…
-
Adma Biologics CEO Grossman trades over $13M in company stock By Investing.com
•
ADMA Biologics, Inc. (NASDAQ: ) has seen significant trading activity from its CEO Adam S. Grossman, according to recent filings. Grossman was involved in acquisitions and stock disposals on Aug. 26 and 27, totaling more than $13 million in transactions. On the purchase side, Grossman acquired approximately $2.9 million worth…
-
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
•
This section is Partnership content provided The content in this section is provided by Business Wire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Business wire Breadcrumb links PMN press releases Business newsletters Article writer: Posted on May 29,…